SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-031059
Filing Date
2024-10-11
Accepted
2024-10-11 08:00:29
Documents
16
Period of Report
2024-10-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K allr20241010_8k.htm   iXBRL 8-K 30663
2 EXHIBIT 99.1 ex_731348.htm EX-99.1 9948
7 atlogosmall.jpg GRAPHIC 5907
  Complete submission text file 0001437749-24-031059.txt   192626

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA allr-20241009.xsd EX-101.SCH 3411
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE allr-20241009_def.xml EX-101.DEF 12189
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE allr-20241009_lab.xml EX-101.LAB 16398
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allr-20241009_pre.xml EX-101.PRE 12459
18 EXTRACTED XBRL INSTANCE DOCUMENT allr20241010_8k_htm.xml XML 3037
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 241366436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)